Payden & Rygel’s Procter & Gamble PG Stock Holding History

Payden & Rygel’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.93M	Sell	54,900 -12,600	-19%	-$1.91M	0.61%	66
2025 Q4	$9.67M	Sell	67,500 -2,400	-3%	-$354K	0.67%	56
2025 Q3	$10.7M	Sell	69,900 -62,500	-47%	-$9.76M	0.89%	52
2025 Q2	$21.1M	Buy	132,400 +800	+0.6%	+$131K	1.75%	19
2025 Q1	$22.4M	Buy	131,600 +60,420	+85%	+$10.1M	1.93%	9
2024 Q4	$11.9M	Sell	71,180 -39,600	-36%	-$6.74M	1.03%	49
2024 Q3	$19.2M	Buy	110,780 +500	+0.5%	+$84.9K	1.48%	24
2024 Q2	$18.2M	Sell	110,280 -10,900	-9%	-$1.78M	1.47%	30
2024 Q1	$19.7M	Buy	121,180 +19,200	+19%	+$3.01M	0.93%	31
2023 Q4	$14.9M	Hold	101,980	–	–	1.04%	50
2023 Q3	$14.9M	Sell	101,980 -2,400	-2%	-$367K	1.02%	38
2023 Q2	$15.8M	Sell	104,380 -69,820	-40%	-$10.5M	1.12%	38
2023 Q1	$25.9M	Buy	+174,200	New	+$24.9M	1.53%	20
2022 Q4	–	Sell	-123,400	Closed	-$15.6M	–	141
2022 Q3	$15.6M	Buy	123,400 +4,300	+4%	+$611K	0.91%	53
2022 Q2	$17.1M	Buy	+119,100	New	+$17.9M	1.03%	51
2021 Q1	–	Sell	-680	Closed	-$95K	–	147
2020 Q4	$95K	Hold	680	–	–	﹤0.01%	118
2020 Q3	$95K	Hold	680	–	–	0.01%	104
2020 Q2	$81K	Hold	680	–	–	0.01%	98
2020 Q1	$75K	Hold	680	–	–	0.01%	98
2019 Q4	$85K	Hold	680	–	–	0.01%	105
2019 Q3	$85K	Hold	680	–	–	0.01%	98
2019 Q2	$75K	Hold	680	–	–	0.01%	104
2019 Q1	$71K	Hold	680	–	–	0.01%	105
2018 Q4	$63K	Hold	680	–	–	0.01%	103
2018 Q3	$57K	Hold	680	–	–	﹤0.01%	105
2018 Q2	$53K	Hold	680	–	–	﹤0.01%	105
2018 Q1	$54K	Hold	680	–	–	﹤0.01%	107
2017 Q4	$62K	Hold	680	–	–	0.01%	103
2017 Q3	$62K	Sell	680 -100,836	-99%	-$9.18M	0.01%	103
2017 Q2	$8.85M	Buy	101,516 +4,799	+5%	+$423K	0.77%	61
2017 Q1	$8.69M	Hold	96,717	–	–	0.79%	61
2016 Q4	$8.13M	Sell	96,717 -17,083	-15%	-$1.46M	0.75%	60
2016 Q3	$10.2M	Hold	113,800	–	–	1.02%	42
2016 Q2	$9.63M	Hold	113,800	–	–	1.1%	45
2016 Q1	$9.37M	Buy	113,800 +800	+0.7%	+$64.5K	1.14%	44
2015 Q4	$8.97M	Buy	113,000 +19,200	+20%	+$1.47M	1.18%	41
2015 Q3	$6.75M	Buy	93,800 +93,000	+11,625%	+$6.97M	0.97%	53
2015 Q2	$63K	Hold	800	–	–	0.01%	110
2015 Q1	$66K	Hold	800	–	–	0.01%	115
2014 Q4	$73K	Hold	800	–	–	0.01%	104
2014 Q3	$67K	Hold	800	–	–	0.01%	112
2014 Q2	$63K	Hold	800	–	–	0.02%	118
2014 Q1	$64K	Hold	800	–	–	0.02%	109
2013 Q4	$65K	Hold	800	–	–	0.02%	146
2013 Q3	$60K	Hold	800	–	–	0.02%	130
2013 Q2	$62K	Buy	+800	New	+$62.8K	0.02%	127

Other funds holding PG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Payden & Rygel's PG Position: Q1 2026 in Review

Payden & Rygel reduced its Procter & Gamble (PG) stake by 19% in Q1 2026, selling an estimated $1.91M and leaving 54,900 shares worth $7.93M. The position accounts for 0.61% of the portfolio, ranked #66.

Payden & Rygel first reported a position in PG in Q2 2013 and has held it in 46 quarters since. The position peaked at $25.9M in Q1 2023. 3,987 funds tracked by Wall St. Rank hold PG as of Q1 2026.

Payden & Rygel held 54,900 shares of Procter & Gamble worth $7.93M as of Q1 2026.
Payden & Rygel sold 12,600 Procter & Gamble shares in Q1 2026, an estimated $1.91M.
Procter & Gamble made up 0.61% of Payden & Rygel's portfolio in Q1 2026, its #66 holding.
Payden & Rygel first reported a position in Procter & Gamble in Q2 2013 and has held it in 46 quarters since.
Payden & Rygel's Procter & Gamble position peaked at $25.9M in Q1 2023.
3,987 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.